Difference between revisions of "Pentraxin 2 (PRM-151)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
 
Line 13: Line 13:
 
[[Category:Drugs]]
 
[[Category:Drugs]]
 
[[Category:Intravenous medications]]
 
[[Category:Intravenous medications]]
 +
[[Category:Recombinant medications]]
  
 
[[Category:Myelofibrosis medications (investigational)]]
 
[[Category:Myelofibrosis medications (investigational)]]

Latest revision as of 14:32, 28 February 2024

General information

Class/mechanism per NCI Drug Dictionary: A fully recombinant form of the human pentraxin 2 (PTX2) protein with potential antifibrotic activity. Upon intravenous administration, recombinant human serum amyloid P/pentraxin 2 (PRM-151) may inhibit myofibroblast generation by preventing the differentiation of circulating monocytes into fibrocytes and profibrotic macrophages. PTX2 is a circulating plasma protein that belongs to the class of pattern recognition receptors (PRR) of the innate immune system.
Route: IV
Extravasation: n/a

Preliminary data

Myelofibrosis

Also known as

  • Code name: PRM-151